This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in the UK and South Africa. According to the US biopharma company, genetic analyses of publicly available sequences for the new variants of SARS-CoV-2 suggest the mutations in the viral spike protein that have made them more transmissible shouldn’t affect the way Veklury (remdesivir) works.
A representative from the global CRO outlines how forces like COVID-19, decentralized studies, globalization and others are driving change in the industry.
The main focus of today’s post is to review the most popular prescription painkillers in the UK. I previously reviewed the popularity of different drugs in the UK, which may interest you: Top 15 most prescribed drugs in the UK & most popular antidepressants in the UK. Most popular prescription painkillers (UK) will be ranked according to the volume of prescriptions issued in the last 12 months by GPs in the UK.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Public health authorities in California are seeking a halt on dosing of one lot of Moderna’s COVID-19 vaccine after reports of allergic reactions at one immunisation clinic. According to state epidemiologist Dr Erica Pan, there were a higher-than-expected number of suspected allergic reactions at a community clinic being used to administer the shot, with some people needing medical attention in a 24-hour period.
A leader from Oracle Health Sciences examines the dynamic, challenging year and highlights creativity and ingenuity displayed by research professionals.
Staying healthy is a priority for most people these days. Sometimes that may mean taking prescription medications that your doctor recommends. Picking up your prescriptions directly from a pharmacy can be challenging with social distancing requirements, illness, or other factors. Mail order pharmacies work through health insurance providers to deliver medications straight to your home.
Staying healthy is a priority for most people these days. Sometimes that may mean taking prescription medications that your doctor recommends. Picking up your prescriptions directly from a pharmacy can be challenging with social distancing requirements, illness, or other factors. Mail order pharmacies work through health insurance providers to deliver medications straight to your home.
A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. CEO Jeremy Edwards looks at how decentralised trial models can solve some of the challenges for clinical trial recruitment in rare disease. With low and geographically dispersed patient populations in rare disease, deciding where best to place trial sites can be a headache for sponsors.
The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.
By Stephen Towers, PhD. The program for this year’s Biotech Showcase Digital – the leading investor and networking conference for mostly small- and mid-cap biotechnology companies – highlighted several important advances in healthcare that have been greatly accelerated by the COVID-19 pandemic (to put a modern spin on the old adage, necessity is the mother of innovation ), including the embrace of digital health and advancement of novel vaccine technologies.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Ella Balasa says she owes her life to the experimental phage therapy she was able access in no small part thanks to her scientific background. Her mission, she told pharmaphorum, is to ensure everyone has the knowledge and power they need to navigate their own healthcare journey, no matter where they are from or what they do. Ella, 28, was diagnosed with cystic fibrosis – a rare genetic disease which causes a build-up of thick, sticky mucus in the lungs, digestive tract, and sinuses – at 18 mont
The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciencesâ VE202 inflammatory bowel disease treatment candidate.
Many pharmacy professionals are needing to juggle increasing job responsibilities with decreasing time to complete tasks. Pharmacy leaders must know not only are they not immune to this, the pharmacy staff they manage isn’t either. As a result everyone on the pharmacy team can often be pulled in many directions. An unfortunate final piece to this introductory framework is the current COVID-19 pandemic.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, and two leading research charities, convened and managed by the Medicines Discovery Catapult, that supports high
The chances are that at some point in the last year when you’ve been talking to someone about how hard it’s been to keep track of and to keep on top of your workload when more and more people are working from home, and everything is so up in the air, that someone will have recommended a management software that they swear by. They will have told you that it has made their work-life immeasurably easier and that they cannot remember how they ever got by without it.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The ABIM Cardiology Board Exam is a difficult test, but the content is very learnable. The average pass rate is ~93% over the past several years, which happens to be higher than most of the other Medical Specialty Boards. On the other hand, Cardiologists may simply be more prepared, and that’s the reason for the higher pass rate. Test your knowledge with some of our sample Cardiology Board Review Practice Questions!
AstraZeneca and Daiichi Sankyo’s Enhertu cancer drug has picked up a second indication, in patients who have stomach cancer and haven’t responded to Roche’s Herceptin (trastuzumab). This latest indication adds to Enhertu first approval at the end of 2019 for advanced HER2-positive breast cancer after two or more HER2-targeted regimens. Around one in five gastric cancers are HER2-positive, opening up a new market niche for AstraZeneca and Daiichi Sankyo, who have been working on Enhertu (trastuzu
A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.
The chances are that at some point in the last year when you’ve been talking to someone about how hard it’s been to keep track of and to keep on top of your workload when more and more people are working from home, and everything is so up in the air, that someone will have recommended a management software that they swear by. They will have told you that it has made their work-life immeasurably easier and that they cannot remember how they ever got by without it.
The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions. New research from CRA shows that for many physician practices, prescribing has shifted based on route of administration. These changes, initially presumed to be temporary, may continue beyond the pandemic. As several COVID-19 vaccine candidates progress to patients and with more than 150 other vaccines in clinical development, global communities look forward
The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment.
Many have asked me what are the pros and cons of doing BCPS recertification by exam. Here are my thoughts on this. BCPS Recertification by Exam: The Pros If you are anything like me, I learn best when I have something I am preparing for. One of the great advantages of preparing to retake the […]. The post BCPS Recertification By Exam Pros and Cons appeared first on Med Ed 101.
A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. In a remote world, customer data is more foundational than ever, and Veeva’s 2020 European Customer Reference Data Survey found 91% of organisations view customer data as a global strategic asset, while 88% said it’s essential for new product launches or sales models.
Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.
Tramadol is used in clinical practice, but it does have numerous drug interactions that you should be aware of. When reviewing a medication list or when a patient starts a new medication, here are some of the items that I think about when monitoring for tramadol drug interactions. Seizure Risk Antiepileptic agents are always something […]. The post Tramadol Drug Interactions appeared first on Med Ed 101.
NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance. The cost-effectiveness body said that trial evidence showed Zeposia cuts the number of relapses and brain lesions compared with Biogen’s Avonex (interferon beta-1a). But in its first draft guidance NICE said that Zeposia’s effect on progression of disability is unclear.
Hello, deprescribers! Today we are excited to have another interview post with clinical pharmacist Pam Howell (Ontario, Canada), telling us about her (deprescribing) experiences working as part of the telemedicine initiative GeriMedRisk. Q: You are part of the GeriMedRisk initiative. First off, can you tell us a little bit about GeriMedRisk and how the consultation service works?
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
141 
Let's personalize your content